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Abstract
Background and objectives: Leigh syndrome (LS) is a rare disease caused by abnormalities of 
mitochondrial energy generation. The central nervous system is most frequently affected, with 
psychomotor underdevelopment, seizures, nystagmus, ophthalmoparesis, optic atrophy, ataxia, 
dystonia, or respiratory failure. Surgical and anesthetic procedures stimulate the tracheal 
irritability, and could exacerbate risks of aspiration, wheezing, breathing difﬁ culties, gasping, 
hypoventilation, and apnea. 
Case Report: We present the anesthetic management for a six-year-old boy with severe form 
of LS, involving repair of a femur fracture. Propofol and remifentanil were infused for general 
anesthesia. The patient was closely monitored during anesthesia and in the intensive care unit 
in the early postoperative period.
Conclusions: Close intraoperative monitoring of patients, including invasive arterial blood pressure 
monitoring and frequently measuring the levels of blood gases, glucose, and lactate, made this 
procedure run smoothly. Intensive care and breathing support for the patient with LS, under 
sedation with an analgesic combination during the early postoperative period, minimized the 
stress response due to pain after surgery.
© 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. 
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Introduction
Leigh syndrome (LS) (subacute necrotizing encephalopathy) 
is a rare disease causing devastating neurodegenerative dis-
order that was ﬁ rst described by Denis Leigh in 1951 1. LS is 
caused by abnormalities of mitochondrial energy generation, 
characterized by brain changes that are almost identical in 
all patients, such as focal, bilaterally symmetric lesions, 
particularly in the basal ganglia, thalamus, and brainstem, 
but with considerable clinical and genetic heterogeneity. 
Deﬁ cits in the respiratory chain (particularly of complexes I, 
II, IV, or V), of coenzyme Q, or of the pyruvate dehydrogenase 
complex are responsible for LS 2. Clinically, it is characterized 
by a wide variety of abnormalities, from severe neurologic 
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intravenously. Propofol 20 mg and cisatracurium 2 mg were 
administered, and a cuffed tracheal tube (ID 5.0 mm) was 
placed through the trachea. Propofol 50-150 μg.kg-1.min-1 
and remifentanil 0.1-0.3 μg.kg-1.min-1 were infused, in order 
to maintain anesthesia. Before the incision was made, one 
gram of ampicillin/sulbactam was given intravenously. A 22-G 
catheter was inserted into the right radial artery for blood 
sampling and continuous monitoring of blood pressure.
Intraoperative monitoring consisted of invasive arterial 
blood pressure, a three-lead electrocardiography, pulse 
oximetry, capnography, esophageal temperature probe, 
and a urethral catheter. Bronchial aspiration was performed 
through the tracheal tube, because of coarse lung sounds. 
During the anesthesia, vital signs were in the range of: blood 
pressure 90-105/55-70 mm Hg; pulse 110-130 beats.min-1; and 
SpO2 97-99%. No hypotensive or hypoxic events were seen. 
Body temperature, values of arterial blood gases, and levels 
of serum lactate and glucose were all within normal range 
during the operation. The femur repair procedure lasted 
1.5h (Figure 2). During the procedure, the patient received 
200 mL of intravenous ﬂ uid. His total urine output was 50 mL. 
While he was still intubated and receiving drug infusions, the 
patient was transferred to the pediatric intensive care unit, 
under pediatrician control.
problems to almost no abnormalities at all. The central nerv-
ous system is most frequently affected with psychomotor 
underdevelopment, seizures, nystagmus, ophthalmoparesis, 
optic atrophy, ataxia, dystonia, or respiratory failure 3. These 
patients are in higher risk for surgery and anesthesia. Surgery 
and anesthesia stimulates the tracheal irritability, and could 
exacerbate risks of aspiration, wheezing, breathing difﬁ cul-
ties, gasping, hypoventilation, and apnea 4. So, anesthetic 
management is crucial in this rare disease. 
We present the anesthetic management for a case with 
LS, involving repair of a femur fracture. The patient was 
closely monitored during anesthesia and in the intensive 
care unit in the early postoperative period. We also discuss 
the anesthetic choices available in literature.
Case report
The patient was a six-year-old boy, weighing 14 kg and 
measuring 120 cm in height, who required anesthetic care 
for surgery to repair a right femur fracture. Patients with LS 
suffer from mental-motor loss of development, necrotizing 
panencephalitis, convulsions, muscle and joint spasticity, 
and respiratory symptoms (episodes of apnea, increased 
airway secretions, and tachypnea). Two years before this 
operation, the patient had suffered from frequent vomit-
ing and bronchopneumonia. For these reasons, he had had 
gastrostomy and fundoplication surgery performed under 
general anesthesia. The patient had needed oxygen and 
steam therapy due to increased airway secretions following 
the operation. His postoperative recovery was delayed and 
he was discharged 31 days after surgery.
The patient was being regularly fed through a gastrostomy 
tube and his family gave him lung physiotherapy for excess 
airway secretions. He also received muscle and joint physi-
otherapy for muscle spasms and spasticity. The patient’s right 
femur had been broken during one of these physiotherapy 
sessions.
Coenzyme Q, vitamin E, clonazepam, carnitine, and 
baclofen were preoperative medications prescribed by the 
primary care physician. Although the patient was conscious 
during the pre-anesthetic visit, he showed no signs of coop-
eration or orientation. He had a gastrostomy catheter. The 
patient has deformities of the thoracic bones and scoliosis, 
and wheezing and rough lung sounds were detected during 
his physical examination (Figure 1). Preoperative labora-
tory evaluation revealed; hemoglobin 12.4 g.dL-1 (13-17), 
hematocrit 37.9% (40-50), a white cell count of 8,800.μL-1 
(4,300-10,300), and a platelet count of 265,000.μL-1 (156,000-
363,000). Glucose was 89 mg.dL-1 (70-110) and his serum 
lactate was 15 mg.dL-1 (4–20). He had been fasting for six 
hours before surgery, in order to prevent aspiration. General 
anesthesia was preferred because of spasticity and difﬁ culty 
in position, and the surgeon requested a neuromuscular 
blocking agent. The patient was constantly monitored after 
he arrived in the operation theatre. His preoperative vital 
signs were as follows: blood pressure 110/70 mm Hg; pulse 
130 beats.min-1; and SpO2 98%.
After anesthesia induction with inhalation of sevoﬂ urane 
in O2/N2O mixture, a 22-gauge intravenous catheter was 
placed in the cubital vein. A 1/3 saline-glucose mixture of 
ﬂ uid was infused as intravenous solution. Sevoﬂ urane and 
N2O were stopped, and remifentanil infusion was started 
Figure 1  The patient has deformities of the thoracic bones 
and scoliosis.
Figure 2  The views of the right femur bone of the patient 
before (a) and after (b) the operation.
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The patient was kept intubated for two days, receiving 
midazolam, fentanyl for sedation and vecuronium for muscle 
relaxation. The patient was extubated two days after the 
procedure and then transferred to orthopedic ward.
Discussion
This patient has the severe abnormalities of the most se-
vere clinical form of LS: psychomotor underdevelopment, 
seizures, nystagmus, ophthalmoparesis, ataxia, respiratory 
failure, repeated lung infections, increase of airway secre-
tions, and severe spasticity. About 50% of individuals affected 
with this disease die by age of three, most often as a result 
of respiratory or cardiac failure 5. Although the patient had 
severe clinical signs, he had reached the age of six because 
of the attentive care and treatments he had received, and 
the absence of serious cardiac failure.
Spinal anesthesia would be appropriate for lower extrem-
ity surgery; as presented for muscle biopsy in a 19-month-old 
with LS without complication 6. However, only a muscle biopsy 
was performed in that case, and the operation lasted just 30 
minutes. In our case, the duration of the operation could not 
be estimated. The choice of general anesthesia was based 
on the surgeon’s request for a neuromuscular blocking agent 
and the difﬁ culty in the patient’s posture due to spasticity 
and the fracture of his femur. 
There are reports on mortality by respiratory failure 
for three patients after general anesthesia 7. Anesthetic 
agents can have potentially serious negative effects in 
LS. Barbiturates and volatile agents can result in lactic 
acidosis and unfavorable metabolic manifestations 4. Since 
vascular access was not in place when the patient came to 
the operating theatre, induction of anesthesia was achieved 
through inhalation of sevoﬂ urane. Shenkman et al. 4 also 
suggest that brief exposure to volatile anesthetics will not 
lead to metabolic deterioration. There are many reports of 
“propofol infusion syndrome” in children, indicating that 
this syndrome is not common with usual doses, but does 
occur when propofol is administered by infusion for more 
than 48 hours, and at a dose of more than 4.5 mg.kg-1.h-1. 
Most patients on short-term infusions show no clinical signs 
of mitochondrial disturbance 8. Since succinylcholine has 
the risk of exaggerated rhabdomyolysis and hyperkalemia, 
it is not preferred in patients with myopathy. We adminis-
tered cisatracurium because the surgery required muscle 
relaxation for a prolonged period of time and the drug’s 
metabolism is free from the function of liver and kidney.
Lactated Ringer solution must be avoided because of its 
lactate content. Also, impaired glucose regulation secondary 
to mitochondrial dysfunction may lead to hypoglycemia dur-
ing the preoperative fasting period, and dextrose containing 
intravenous ﬂ uids should be administered to maintain an 
euglycemic condition with frequent assessment of blood 
glucose levels during prolonged fasting 6. We used glucose-
saline solution for intravenous ﬂ uid therapy. To monitor 
metabolic changes during the operation, arterial blood gases 
and lactate levels were measured at frequent intervals. They 
were all within normal limits. Although there was no sign of 
infection in our case, there was evidence of increased airway 
secretions. Therefore, preoperative antibiotic prophylaxis 
was given, and bronchial aspiration was performed through 
the tracheal tube.
Because of the presence of preoperative reactive airways 
in patients who exhibit a severe picture of LS, the risk of 
postoperative respiratory complications is high. Anesthetic 
procedures stimulate the tracheal irritability, and could ex-
acerbate the risk of pulmonary complications 4. Long-term 
postoperative sedation is necessary to prevent the surgical 
stress, to reduce the risk of tracheal irritability and aspira-
tion, and to protect wounds from the effects of the invol-
untary movements of patients with LS 9. To ensure this was 
regularly monitored and that the patient received effective 
early treatment for pain, he was transferred to the pediatric 
intensive care unit under sedation. Hemodynamic, clinical 
and metabolic aspects of the patient were closely followed, 
and his tracheal tube was removed two days later.
In conclusion, selecting anesthetic agents carefully, 
close intraoperative monitoring of patients and frequently 
measuring the levels of blood gases, glucose, and lactate, 
are important. Intensive care and breathing support for the 
patient with LS, under sedation with an analgesic combina-
tion guarantee good pain control and a less stressful early 
postoperative period.
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